Naloxone Hydrochloride Injection, Solution
Product Images NDC 55150-345

11 FDA label images from Eugia Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 55150-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Naloxone Str)

Chemical-structure (Naloxone Str)
Chemical structure of Naloxone Hydrochloride showing the molecular diagram and its chemical name including stereochemistry and functional groups.*
FDA Label Image

Naloxone-fig1 (Naloxone Fig1)

Naloxone-fig1 (Naloxone Fig1)
This black-and-white instructional image shows a person wearing gloves preparing a syringe for injection, illustrating the handling of a prefilled syringe likely containing Naloxone Hydrochloride injection solution. The image emphasizes proper technique to hold and assemble the syringe and needle prior to administration.*
FDA Label Image

Naloxone-figure-2 (Naloxone Fig2)

Naloxone-figure-2 (Naloxone Fig2)
An instructional illustration showing gloved hands preparing a naloxone hydrochloride injection solution. One hand holds an ampule, while the other uses a syringe to draw the medication from the ampule. This depicts the preparation step for intramuscular, intravenous, or subcutaneous administration.*
FDA Label Image

Naloxone-figure-3 (Naloxone Fig3)

Naloxone-figure-3 (Naloxone Fig3)
Naloxone Hydrochloride 1 mg/mL injection solution in a prefilled syringe is shown being held by a gloved hand. The syringe displays measurement markings for dosing. The product is labeled as an injectable solution for intramuscular, intravenous, and subcutaneous use, manufactured by Eugia US LLC.*
FDA Label Image

Naloxone-figure-4 (Naloxone Fig4)

Naloxone-figure-4 (Naloxone Fig4)
Naloxone Hydrochloride USP Injection, 2 mg per 2 mL (1 mg/mL) in a 2 mL single dose prefilled syringe. The label indicates use for intravenous, intramuscular, or subcutaneous administration. It is preservative free, to be protected from light, and unused portions should be discarded. Manufactured in India for Eugia US LLC by AuroMedics Pharma LLC.*
FDA Label Image

Naloxone-figure-5 (Naloxone Fig5)

Naloxone-figure-5 (Naloxone Fig5)
Label for Naloxone Hydrochloride Injection, USP, 1 mg/mL (2 mg per 2 mL) in a single dose disposable prefilled syringe. The label states it is for intravenous, intramuscular, or subcutaneous use as an opioid antagonist. It includes NDC 55150-345-01, distributor info for AuroMedics Pharma LLC, storage instructions, and barcode.*
FDA Label Image

Naloxone-figure-5 (Naloxone Fig6)

Naloxone-figure-5 (Naloxone Fig6)
Packaging label for Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) by Auromedics, distributed by AuroMedics Pharma LLC. The label specifies the product as a single-dose, preservative-free injectable solution for intravenous, intramuscular, or subcutaneous use, supplied in a 2 mL Luer-Lock prefilled disposable syringe. The NDC is 55150-345-01. Storage and usage instructions are included.*
FDA Label Image

Naloxone-figure-7 (Naloxone Fig7)

Naloxone-figure-7 (Naloxone Fig7)
Naloxone Hydrochloride Injection, USP label and carton for a prefilled Luer-Lock syringe. The strength shown is 2 mg per 2 mL (1 mg/mL). The product is for intravenous, intramuscular, or subcutaneous use. The package contains 10 x 2 mL single-dose disposable prefilled syringes. Distributed by AuroMedics Pharma LLC, with storage instructions and labeling details included.*
FDA Label Image

Naloxone-fig8 (Naloxone Fig8)

Naloxone-fig8 (Naloxone Fig8)
Label for Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) in a 2 mL single dose prefilled syringe. The label indicates it is preservative free, designed for IV, IM, or SC use, and manufactured for Eugia US LLC. It includes NDC 55150-345-01 and barcode.*
FDA Label Image

Naloxone-fig9 (Naloxone Fig9)

Naloxone-fig9 (Naloxone Fig9)
Packaging label for Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) solution. Distributed by Eugia US LLC, the label indicates a single-dose, preservative-free prefilled syringe for intravenous, intramuscular, or subcutaneous use. The label includes dosage instructions, storage conditions, and notes that the needle is not included. The product is sterile and nonpyrogenic, with an NDC of 55150-345-01.*
FDA Label Image

Package Label-principal Display Panel-2 mg Per 2 mL (1 mg/ml) (Syringe-Carton (10 Syringes))

Package Label-principal Display Panel-2 mg Per 2 mL (1 mg/ml) (Syringe-Carton (10 Syringes))
Packaging label for Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) by Eugia US LLC. The product is a Luer-Lock prefilled syringe for intravenous, intramuscular, or subcutaneous use. The package contains ten 2 mL single-dose disposable prefilled syringes. The label notes the product is preservative-free, sterile, and for opioid antagonist use, with needle not included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.